03/11/2026
WOW!
"The Obesity Society, the Obesity Medicine Association and the Obesity Action Coalition have issued guidance published in the journal Obesity on pharmacologic treatment of obesity providing recommendations based on existing evidence for all US-approved medications. Strong recommendations are given for bupropion-naltrexone, semaglutide and tirzepatide. The guidance stresses the chronic nature of obesity and the safety and efficacy of medications, and it aims to inform decision-making."
If you have questions about weight loss drugs, please ask your Xpress Pharmacist. We are here to help!